The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to quantify the economic burden of chronic obstructive pulmonary disease (COPD) across 204 countries and territories from 2020 to 2050.
Health-augmented macroeconomic modelling implemented to assess financial impacts.
Analysis conducted on a global scale, covering 204 regions.
Cost implications assessed for different time frames up to 2050.
Projected significant economic losses attributed to COPD, straining healthcare resources and national economies.
Increased prevalence of COPD expected to escalate direct and indirect costs over the specified period.
Findings highlight the need for improved preventive measures and healthcare policies to mitigate economic impacts.

We only have this paper's title and publication details.

Health-augmented macroeconomic modelling shows significant economic burden of COPD worldwide, suggesting urgent policy action.

For the Chinese and German translations of the abstract see Supplementary Materials section.

No takes yet. Share an insight, caveat, or question.

Chen et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark

Share